News : Elekta

View:
 

Found press releases

 

Year-end report May – April 2012/13


· Order bookings increased 14* percent to SEK 12,117 M (10,815).
· Net sales increased 16* percent to SEK 10,339 M (9,048).
· Operating result amounted to SEK 2,058 M (1,837) excluding non-recurring items of SEK -46 M (12).
· Net income amounted to SEK 1,351 M (1,228). Earnings per share amounted to SEK 3.52 (3.26) before dilution and SEK 3.52 (3.23) after dilution.
· Cash flow after continuous investments was...

New Clarity Soft Tissue Visualization Software Neutralizes Organ Motion Challeng...

Elekta receives FDA 510(k) clearance for Clarity 4D Monitoring
Stockholm, December 17, 2012 – Elekta has received 510(k) clearance for its Clarity® 4D Monitoring software, enabling U.S. medical centers to implement this new way of reducing the uncertainty caused by prostate motion during radiation treatment. Physicians will be able to monitor the motion of the prostate and surrounding tissues and organs – in...

Elekta and Key Distributor Enter Agreement to Increase Production Efforts of Rad...

Stockholm, SWEDEN, October 29, 2012 – Elekta, a world leader in the design and manufacture of cancer treatment technology and software, and MSM-MEDIMPEX, a major Russian medical technology distributor, have announced their intention to set up production of radiotherapy equipment in Russia, with the intent to improve access to radiation therapy treatments to Russian citizens afflicted with cancer. Russia is the...

Danish Clinics Anticipate Benefits for Cancer Patients with Elekta’s Innovative ...

Vejle Hospital and Odense University Hospital acquire Elekta treatment systems equipped with Elekta’s Agility MLC
ODENSE and VEJLE, Denmark, Oct. 8, 2012 – Odense University Hospital (OUH) and Vejle Hospital will be the first Danish medical centers to use Elekta treatment systems with an integrated Agility™* 160-leaf multi-leaf collimator (MLC). Physicists at both clinics expect patients with cancer will...

Number of outstanding shares in Elekta AB (publ)

During August and September no new shares were issued.

The total number of shares in Elekta as of September 28, 2012, after the recently conducted 4:1 share split, amounts to 382,806,680 divided between 14,250,000 A shares and 368,556,680 B shares.

One A share entitles the holder to ten votes and one B share to one vote.

******

                   

For further information, please contact:
Johan Andersson Melbi,...

Recalculation of conversion price for Elekta’s convertible bond due to resolutio...

On September 4, 2012, Elekta’s Annual General Meeting resolved on a split of the Company’s shares, whereby each existing share with a quotient value of SEK 2.00 will be divided into four new shares with a quotient value of SEK 0.50, without changing the Company’s share capital. The total number of shares prior to the split is 95,701,670, represented by 3,562,500 series A shares and 92,139,170 series B shares....

Elekta’s annual report for 2011/12 is now available on the Company’s website

Elekta’s annual report 2011/12 has been published and can be downloaded from the investor section on the Elekta web, www.elekta.com, and is also enclosed with this press release.

The printed annual report is under distribution to the shareholders who have requested to receive it. Elekta’s Annual General Meeting takes place September 4, 2012, at 3:00 p.m. at Stockholm Waterfront Congress Centre.

To request...

Elekta strengthens its position in Brazil with acquisition of Radon Ltda.

Press Release
Stockholm, Sweden, June 19, 2012

Elekta has today acquired Radon Ltda. group, the leading linear accelerator (linac) service company in Brazil. Most of the service contracts held by the company are with clinics that use equipment delivered by Siemens. The acquisition significantly strengthens Elekta’s market position, making it the leading organization for installation, service and aftermarket...

Elekta’s Nomination Committee proposal for the election of Board of Directors an...

Press Release
Stockholm, Sweden, June 18, 2012

The Nomination Committee of Elekta AB (publ) proposes the following to the company’s Annual General Meeting on September 4, 2012.

The Nomination Committee of Elekta AB (publ) proposes that the Board of Directors consists of eight members. The Nomination Committee proposes the re-election of Akbar Seddigh, Hans Barella, Luciano Cattani, Laurent Leksell, Siaou-Sze Lien,...

U.K.’s NHS Supply Chain Signs Agreement to Acquire 10 Elekta Linear Accelerator ...

Advanced Elekta Synergy radiation therapy systems to modernize treatment capabilities in NHS hospitals
CRAWLEY, England, June 18 – NHS Supply Chain will bring state-of-the-art cancer treatment to the United Kingdom by signing a deal to purchase ten Elekta...